| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb596f03d029321340c965e75de6564a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-50 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6815
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate |
2012-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef8c1e952a8e0083b709f1ec7715073c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b14e4ffc35fb9857de9e6b68fa79f40a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e7d1be5cdbc9102f57b9982ab2dfefd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd7d2bdea52102dddc5fb338d57acda3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0f37ac8b2b024f114fc11f53be0dbf7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a67a4f077cb5086c0e5600f8bc1fcff |
| publicationDate |
2016-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NZ-623726-A |
| titleOfInvention |
Blood coagulation factor ⅶ and ⅶa derivatives, conjugates and complexes comprising the same, and use thereof |
| abstract |
Disclosed is a derivative of FacⅦ or its active form FacⅦa, comprising the amino acid sequence of SEQ ID NO. 4 from FacⅦ and a peptide linker linked at the C-terminus thereof, wherein the C-terminal amino acid residue of the peptide linker is a cysteine, wherein the sequence is defined in the complete specification. Also disclosed is the use of said compound for the preparation of a medicament for preventing or treating haemophilia or for promoting blood coagulation. |
| priorityDate |
2011-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |